Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Hepatology

• Publication date

  2011-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jhep.2011.02.013PMID 21354231PMCID PMC3611963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

  2011cited by this paper
• HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.

  2010cited by this paper
• Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene Mutation

  2010cited by this paper
• An Epidemiologic Study on the Incidence and Significance of HFE Mutations in a Korean Cohort With Nonalcoholic Fatty Liver Disease

  2010cited by this paper
• Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.

  2010cited by this paper
• Suppressive effects of retinoids on iron-induced oxidative stress in the liver.

  2009cited by this paper
• The epidemiology of nonalcoholic fatty liver disease: a global perspective.

  2008cited by this paper
• Iron overload alters glucose homeostasis, causes liver steatosis, and increases serum triacylglycerols in rats.

  2008cited by this paper
• Steatosis, iron and HFE genes

  2008cited by this paper
• The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations

  2008cited by this paper
• Bloodletting Ameliorates Insulin Sensitivity and Secretion in Parallel to Reducing Liver Iron in Carriers of HFE Gene Mutations

  2008cited by this paper
• Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified.

  2008cited by this paper
• Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.

  2008cited by this paper
• The Clinicopathological Profile of Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD) is Different from That in the West

  2007cited by this paper
• HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis

  2007cited by this paper
• An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy

  2007cited by this paper
• Hemochromatosis genotypes and risk of 31 disease endpoints: Meta‐analyses including 66,000 cases and 226,000 controls

  2007cited by this paper
• The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.

  2006cited by this paper
• Individuals Homozygous for the H63D Mutation Have Significantly Elevated Iron Indexes

  2006cited by this paper
• Long‐term follow‐up of patients with NAFLD and elevated liver enzymes

  2006cited by this paper
• Genes or environment to determine alcoholic liver disease and non‐alcoholic fatty liver disease

  2006cited by this paper
• Comparison of two methods to detect publication bias in meta-analysis.

  2006cited by this paper
• Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.

  2006cited by this paper
• α1‐Antitrypsin mutations in NAFLD: High prevalence and association with altered iron metabolism but not with liver damage

  2006cited by this paper
• HFE Mutations Analysis of Turkish Patients with Nonalcoholic Steatohepatitis

  2006cited by this paper
• Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.

  2005cited by this paper
• Hemochromatosis and iron-overload screening in a racially diverse population.

  2005cited by this paper
• HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment.

  2005cited by this paper
• Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

  2004cited by this paper
• Consensus Statement

  2004cited by this paper
• Estudio de pacientes remitidos por elevación de la ferritina y/o saturación de la transferrina: importancia del hígado graso no alcohólico

  2004cited by this paper
• Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

  2004cited by this paper
• [Study of patients referred for elevated ferritin levels and/or transferrin saturation: significance of non-alcoholic fatty liver disease].

  2004cited by this paper
• The origin and spread of the HFE-C282Y haemochromatosis mutation

  2004cited by this paper
• Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis

  2004cited by this paper
• [Dysmetabolic hepatosiderosis, characteristics in 51 patients].

  2003cited by this paper
• Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings

  2003cited by this paper
• Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis

  2003cited by this paper
• Non-alcoholic steatohepatitis (NASH) and chronic hepatitis C

  2002cited by this paper
• Cross-talk between iron metabolism and diabetes.

  2002cited by this paper
• [Non alcoholic steatohepatitis: a multifactorial, frequent, paucysymptomatic liver disease with a fibrotic outcome].

  2002cited by this paper
• HFE mutations, hepatic iron, and fibrosis: Ethnic‐specific association of NASH with C282Y but not with fibrotic severity

  2002cited by this paper
• American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease.

  2002cited by this paper
• Iron status and HFE gene mutations in non-alcoholic steatohepatitis (NASH)

  2002cited by this paper
• Methods for Exploring Heterogeneity in Meta-Analysis

  2001cited by this paper
• Nonalcoholic Steatohepatitis: Definition and Pathology

  2001cited by this paper
• Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

  2001cited by this paper
• Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.

  2001cited by this paper
• Methods for exploring heterogeneity in meta-analysis.

  2001cited by this paper
• HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases

  2000cited by this paper
• Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload?

  2000cited by this paper
• Histological evaluation of iron in liver biopsies: relationship to HFE mutations

  2000cited by this paper
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

  2000cited by this paper
• Letters to the Editor: Non-alcoholic steatohepatitis with iron: part of insulin resistanceassociated hepatic iron overload?

  2000cited by this paper
• Insulin resistance-associated hepatic iron overload.

  1999cited by this paper
• Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.

  1999cited by this paper
• Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats

  1999cited by this paper
• Hepatic iron and nonalcoholic fatty liver disease

  1999cited by this paper
• Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening

  1998cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

  1998cited by this paper
• The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression*

  1997cited by this paper
• PS power and sample size program available for free on the internet

  1997cited by this paper
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

  1996cited by this paper
• Guidelines and Guidance Strengthening the Reporting of Genetic Association Studies (strega)— an Extension of the Strobe Statement the Guidelines and Guidance Section Contains Advice on Conducting and Reporting Genotyping Errors Population Stratification

  year unknowncited by this paper

• Association between pattern of hepatic iron deposition and severity of MASH among patients enrolled in the NASH Clinical Research Network

  2025cites this paper
• A decade of iron overload disorders and hemochromatosis: clinical and genetic findings from a specialized center in Colombia

  2024cites this paper
• Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond

  2024cites this paper
• Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals

  2023cites this paper
• Genetic Markers Predisposing to Nonalcoholic Steatohepatitis.

  2023cites this paper
• Secondary Iron Overload and the Liver: A Comprehensive Review

  2023cites this paper
• Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes

  2022cites this paper
• Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.

  2021cites this paper
• Whole-body R2∗ mapping to quantify tissue iron in iron storage organs: reference values and a genotype.

  2021cites this paper
• Multiparametric MR mapping in clinical decision-making for diffuse liver disease

  2020cites this paper
• Role of molecular genetic factors in pathogenesis and diagnosis of non-alcoholic fatty liver disease (literature review and own data)

  2020cites this paper
• Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics

  2019cites this paper
• Genomic studies in non-alcoholic fatty liver disease

  2017cites this paper
• Effect of total body iron on metabolic dysfunction among U.S. females in the Nhanes 2003-2010, aged 12-49.

  2017cites this paper
• Association of HFE gene mutations with nonalcoholic fatty liver disease in the Iranian population.

  2016cites this paper
• Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls

  2016cites this paper
• HFE genetic variability and risk of alcoholic liver disease: A meta-analysis

  2016cites this paper
• Iron and non-alcoholic fatty liver disease

  2016cites this paper
• A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence

  2016cites this paper
• Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.

  2016cites this paper
• HFE genetic variability and risk of alcoholic liver disease: A meta-analysis

  2016cites this paper
• Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

  2015cites this paper
• A career forged in iron

  2015influential citation
• The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2

  2015cites this paper
• Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries.

  2015cites this paper
• Effects of iron overload on chronic metabolic diseases.

  2014cites this paper
• Caracterización del papel de la ácido graso translocasa CD36 en la enfermedad hepática grasa no alcohólica y en la hepatitis crónica por virus C

  2014cites this paper
• Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation

  2014cites this paper
• Host genetic variants in obesity-related nonalcoholic fatty liver disease.

  2014cites this paper
• Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

  2013cites this paper
• Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease : A narrative review

  2013cites this paper
• Iron homeostasis in the Metabolic Syndrome

  2013cites this paper
• Hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: a meta-analysis.

  2012cites this paper
• Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations

  2012cites this paper
• Iron Metabolism in Nonalcoholic Fatty Liver Disease

  2012cites this paper
• Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review.

  2012cites this paper
• Re: "hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: a meta-analysis".

  2012cites this paper
• Systematic Reviews and Meta-and Pooled Analyses Hemochromatosis Gene ( HFE ) Polymorphisms and Risk of Type 2 Diabetes Mellitus : A Meta-Analysis

  2012cites this paper
• Genetics of non-alcoholic fatty liver disease and associated metabolic disorders

  2011cites this paper
• Non-alcoholic fatty liver disease: is iron relevant?

  2011cites this paper
• Cryptogenic Chronic Hepatitis and Its Changing Guise in Adults

  2011cites this paper
• Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

  2011cites this paper